We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » MRC Technology appoints Steve Visscher new trustee

MRC Technology appoints Steve Visscher new trustee

January 30, 2017
CenterWatch Staff

MRC Technology, an independent life science medical research charity, has appointed Steve Visscher CBE, currently BBSRC deputy chief executive–International, to its board of trustees.

MRC Technology (MRCT) progresses medical research in areas where there is unmet patient need. It has helped to launch treatments for advanced melanoma, non-small-cell lung cancer, rheumatoid arthritis, multiple sclerosis and Crohn’s disease. The charity’s trustees have extensive expertise across the biomedical sciences, biotech and pharma industry, finance, law and medicine to support strategic direction in the delivery of its charitable objects.

Dr. John Stageman, chairman, MRC Technology, said, “I am delighted to welcome Steve to the board of trustees. Our board plays a pivotal role in ensuring the charity stays focused on the activities that will make the biggest impact to improve patients’ lives. Collaborative working with academia, healthcare companies and charities is a key strength for us, and Steve’s extensive experience of Research Council leadership, strategic finance and building international research partnerships will be a great asset to the board at this exciting time in MRCT’s development.”

Steve Visscher commented, “MRC Technology has a unique and valuable role among medical charities. I look forward to contributing to its strategic development as it deploys proven research and commercial expertise in new and established ways to further its charitable goals.”

Europe Awards & Advancement

Upcoming Events

  • 09Dec

    The Age of eSource: Modernizing Clinical Trials

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Patient-phsyician-consultation

    Giving Patients Back Their Voice in Clinical Trials

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing